tiprankstipranks
Trending News
More News >
Cosmo Bio Co., Ltd. (JP:3386)
:3386
Japanese Market

Cosmo Bio Co., Ltd. (3386) Financial Statements

Compare
0 Followers

Cosmo Bio Co., Ltd. Financial Overview

Cosmo Bio Co., Ltd.'s market cap is currently ¥7.63B. The company's EPS TTM is ¥3.93; its P/E ratio is 30.89; and it has a dividend yield of 4.57%. Cosmo Bio Co., Ltd. is scheduled to report earnings on November 7, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 10.04B¥ 9.34B¥ 9.55B¥ 9.23B¥ 8.09B
Gross Profit¥ 3.33B¥ 3.25B¥ 3.44B¥ 3.66B¥ 3.15B
Operating Income¥ 318.00M¥ 519.00M¥ 816.00M¥ 1.05B¥ 752.00M
EBITDA¥ 455.00M¥ 801.00M¥ 931.00M¥ 1.26B¥ 1.18B
Net Income¥ 262.00M¥ 442.00M¥ 517.00M¥ 737.00M¥ 674.00M
Balance Sheet
Cash & Short-Term Investments¥ 2.69B¥ 3.02B¥ 3.04B¥ 3.56B¥ 3.26B
Total Assets¥ 11.72B¥ 10.87B¥ 10.31B¥ 10.07B¥ 9.64B
Total Debt¥ 20.00M¥ 20.00M¥ 20.00M¥ 20.00M¥ 20.00M
Net Debt¥ -2.37B¥ -2.81B¥ -3.02B¥ -3.23B¥ -3.14B
Total Liabilities¥ 2.17B¥ 1.85B¥ 1.70B¥ 1.75B¥ 1.78B
Stockholders' Equity¥ 8.97B¥ 8.45B¥ 8.05B¥ 7.79B¥ 7.36B
Cash Flow
Free Cash Flow¥ 25.00M¥ 636.00M¥ 180.00M¥ 507.00M¥ 738.00M
Operating Cash Flow¥ 241.00M¥ 736.00M¥ 284.00M¥ 648.00M¥ 803.00M
Investing Cash Flow¥ -217.00M¥ -758.00M¥ -291.00M¥ -145.00M¥ 42.00M
Financing Cash Flow¥ -479.00M¥ -201.00M¥ -236.00M¥ -420.00M¥ -97.00M
Currency in JPY

Cosmo Bio Co., Ltd. Earnings and Revenue History

Cosmo Bio Co., Ltd. Debt to Assets

Cosmo Bio Co., Ltd. Cash Flow

Cosmo Bio Co., Ltd. Forecast EPS vs Actual EPS